PHARMACOLOGICAL TREATMENT FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) IN PEDIATRIC PATIENTS

Authors

DOI:

https://doi.org/10.47820/recima21.v4i1.2633

Keywords:

GERD is a condition of uncomfortable symptoms and complications

Abstract

Introduction: GERD is a condition of uncomfortable symptoms and complications that result from the reflux of stomach contents into the esophagus. Studies suggest that it occurs in about 50% of infants younger than 2 months of age, 60 to 70% of infants aged 3 to 4 months, and 5% of infants aged 12 months. The aim is to gather evidence to confirm the safety of drug treatment for GERD in children. Materials and methods: The research was carried out using the following descriptors: “gastroesophageal reflux diseases”, “children” and “drug treatment” combined with Boolean operators. By applying all the inclusion and exclusion criteria, a sample of 5 articles was obtained. Results and discussion: Drug treatment of GERD basically consists of proton pump inhibitor drugs (PPIs), which block the final step of gastric acid release due to inhibition of the H+/K+-ATPase enzyme. Regarding the association of non-drug methods to acid suppression therapy, a randomized clinical trial was carried out with the aim of clarifying the superiority of the combined treatment. Conclusion: It is concluded that treatment with PPIs and even the off-label use of metoclopramide can be beneficial as anti-reflux therapy in the pediatric population.

Downloads

Download data is not yet available.

Author Biographies

Estela de Oliveira Rodrigues, Universidade José do Rosário Vellano - UNIFENAS

Acadêmica de Medicina na Universidade José do Rosário Vellano - UNIFENAS, do sexto período.

Afonso Vilela Neves Júnior, Universidade José do Rosário Vellano - UNIFENAS

Acadêmico de Medicina na Universidade José do Rosário Vellano - UNIFENAS, do nono período.

Amanda Carolline Couto, UNIPAC- Centro Universitário Presidente Antonio Carlos

Acadêmica de Medicina na UNIPAC- Centro universitário presidente Antônio Carlos , do quinto período.

Camila de Alencastro Costa Moreira , Faculdade Municipal Professor Franco Montoro

Acadêmica de Medicina na Universidade Municipal Franco Montoro - FMPFM, do segundo período.

Elisangela Vaz Kochhann, Centro Universitário de Jaguariúna

Acadêmica de Medicina no Centro Universitário de Jaguariúna.

Giovani Caiolli Noel Scapin Santos, Universidade José do Rosário Vellano - UNIFENAS

Acadêmico de Medicina na Universidade José do Rosário Vellano - UNIFENAS, do décimo primeiro período.

Isabella Loiola Lima, Universidade José do Rosário Vellano - UNIFENAS

Médica formada pela Universidade José do Rosário Vellano - UNIFENAS.

Izadora Pires de Oliveira, Universidade José do Rosário Vellano - UNIFENAS

Acadêmica de Medicina na Universidade José do Rosário Vellano - UNIFENAS, do sétimo período.

Marina Santana Fonseca, Associação São Francisco de Assis

Graduada pela Unifenas, residente em Cirurgia Geral pela Associação São Francisco de Assis (Hospital Cemil), Umuarama-PR.

Carollayne Mendonça Rocha, Universidade José do Rosário Vellano - UNIFENAS

Universidade José do Rosário Vellano - UNIFENAS.

References

Clarrett DM, Hachem C. Gastroesophageal Reflux Disease (GERD). Mo Med. 2018 May-Jun;115(3):214-218. PMID: 30228725; PMCID: PMC6140167.

Leung AK, Hon KL. Gastroesophageal reflux in children: an updated review. Drugs Context. 2019 Jun 17;8:212591. doi: 10.7573/dic.212591. PMID: 31258618; PMCID: PMC6586172.

Ferguson TD. Gastroesophageal Reflux: Regurgitation in the Infant Population. Crit Care Nurs Clin North Am. 2018 Mar;30(1):167-177. doi: 10.1016/j.cnc.2017.10.015. Epub 2017 Dec 1. PMID: 29413212.

Arcos-Machancoses JV, Ruiz Hernández C, Martin de Carpi J, Pinillos Pisón S. A systematic review with meta-analysis of the prevalence of gastroesophageal reflux in congenital diaphragmatic hernia pediatric survivors. Dis Esophagus. 2018 Jun 1;31(6). doi: 10.1093/dote/dox158. PMID: 29444224.

Maqbool A, Pauwels A. Cystic Fibrosis and gastroesophageal reflux disease. J Cyst Fibros. 2017 Nov;16 Suppl 2:S2-S13. doi: 10.1016/j.jcf.2017.07.007. PMID: 28986024.

Orenstein SR, Shalaby TM, Finch R, Pfuetzer RH, DeVandry S, Chensny LJ, Bannada MM, Whitcomb DC. Autosomal dominant infantile gastroesophageal reflux disease: exclusion of a 13q14 locus in five well characterized families. Am J Gastroenterol. 2002 Nov;97(11):2725-32. doi: 10.1111/j.1572-0241.2002.07060.x. PMID: 12425539.

Leung AK, Chan KW. Iron deficiency anemia. Adv Pediatr. 2001;48:385-408. PMID: 11480764.

Slater BJ, Rothenberg SS. Gastroesophageal reflux. Semin Pediatr Surg. 2017;26(2):56–60. doi: 10.1053/j.sempedsurg.2017.02.007.

Mousa H, Hassan M. Gastroesophageal reflux disease. Pediatr Clin North Am. 2017;64(3):487–505. doi: 10.1016/j.pcl.2017.01.003.

Sarath Kumar KS, Mungara J, Venumbaka NR, Vijayakumar P, Karunakaran D. Oral manifestations of gastroesophageal reflux disease in children: a preliminary observational study. J Indian Soc Pedod Prev Dent. 2018;36(2):125–129. doi: 10.4103/JISPPD.JISPPD_1182_17.

Ciciora SL, Woodley FW. Optimizing the use of medications and other therapies in infant gastroesophageal reflux. Paediatr Drugs. 2018;20(6):523–537. doi: 10.1007/s40272-018-0311-3.

Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) J Pediatr Gastroenterol Nutr. 2018;66(3):516–554. doi: 10.1097/MPG.0000000000001889.

Kwok TC, Ojha S, Dorling J. Feed thickener for infants up to six months of age with gastro-oesophageal reflux. Cochrane Database Syst Rev. 2017;12:CD003211. doi: 10.1002/14651858.CD003211.pub2.

SOUZA, Marcela Tavares de; SILVA, Michelly Dias da; CARVALHO, Rachel de. Revisão integrativa: o que é e como fazer. Einstein (São Paulo), v. 8, p. 102-106, 2010.

MENDES, Karina Dal Sasso; SILVEIRA, Renata Cristina de Campos Pereira; GALVÃO, Cristina Maria. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & contexto-enfermagem, v. 17, p. 758-764, 2008.

Bestebreurtje P, de Koning BAE, Roeleveld N, et al. Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial. Eur J Drug Metab Pharmacokinet. 2020;45(5):635. doi:10.1007/S13318-020-00630-8

Ge S, Mendley SR, Gerhart JG, et al. Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents. Clin Transl Sci. 2020;13(6):1189. doi:10.1111/CTS.12803

Dziekiewicz M, Mielus M, Lisowska A, et al. Effect of omeprazole on symptoms of gastroesophageal reflux disease in children with cystic fibrosis. A randomized, double-blind, placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2021;25(2):999-1005. doi:10.26355/EURREV_202101_24669

Nobile S, Meneghin F, Marchionni P, et al. Response to therapy among neonates with gastro-esophageal reflux is associated with esophageal clearance. Early Hum Dev. 2021;152. doi:10.1016/J.EARLHUMDEV.2020.105248

Jadcherla SR, Hasenstab KA, Gulati IK, et al. Impact of Feeding Strategies With Acid Suppression on Esophageal Reflexes in Human Neonates With Gastroesophageal Reflux Disease: A Single-Blinded Randomized Clinical Trial. Clin Transl Gastroenterol. 2020;11(11):e00249. doi:10.14309/CTG.0000000000000249

RECIMA21

Downloads

Published

15/01/2023

How to Cite

de Oliveira Rodrigues, E., Vilela Neves Júnior, A., Carolline Couto, A., de Alencastro Costa Moreira , C., Vaz Kochhann, E., Caiolli Noel Scapin Santos, G., … Mendonça Rocha, C. (2023). PHARMACOLOGICAL TREATMENT FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) IN PEDIATRIC PATIENTS. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 4(1), e412633. https://doi.org/10.47820/recima21.v4i1.2633

Issue

Vol. 4 No. 1 (2023): EDITORIAL - CLICK HERE TO ACCESS THE ARTICLES

Section

ARTIGOS

Categories

License

Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores  e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.